Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This study will be executed according to a randomized double-blind placebo-controlled trial with two parallel groups, treated over the period of 6 months with escitalopram or placebo. Hypotheses: Escitalopram is more effective than placebo in the control of gastrointestinal symptoms, in irritable bowel syndrome (IBS) patients with panic disorder. Escitalopram is more effective than placebo in the control of psychiatric symptoms, in IBS patients with panic disorder.
Epistemonikos ID: 908b4c4067cdf62ef80f3571f8c7d53bf2da16d5
First added on: May 10, 2024